etoposide phosphate has been researched along with Leukocytopenia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbhaiya, RH; Garrow, C; Greco, A; Hainsworth, JD; Igwenezue, KB; Kaul, S; Miller, AA; Schacter, LP; Srinivas, NR; Thompson, DS | 1 |
Barbhaiya, RH; Fields, SZ; Himpler, BS; Igwemezie, LN; Kaul, S; Litam, PP; McAleer, C; Schacter, LP; Schilder, RJ; Wright, J | 1 |
2 trial(s) available for etoposide phosphate and Leukocytopenia
Article | Year |
---|---|
A phase I study of etoposide phosphate administered as a daily 30-minute infusion for 5 days.
Topics: Adult; Aged; Antineoplastic Agents; Chromatography, High Pressure Liquid; Cohort Studies; Dose-Response Relationship, Drug; Etoposide; Female; Half-Life; Humans; Infusions, Intravenous; Leukopenia; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Organophosphorus Compounds | 1995 |
Phase I study of etoposide phosphate (etopophos) as a 30-minute infusion on days 1, 3, and 5.
Topics: Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Half-Life; Hemoglobins; Humans; Infusions, Intravenous; Leukopenia; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Organophosphorus Compounds; Thrombocytopenia | 1995 |